26868132|t|Association of RBP4 levels with increased arterial stiffness in adolescents with family history of type 2 diabetes
26868132|a|The aim of this study was to explore the impact of family history of type 2 diabetes (FH2D) on arterial stiffness in young people and its relationship to adipocytokines. This case-control study included 52 adolescents (male / female 28/24) with FH2D (FH2D+) and 40 adolescents (male / female 21/19) without FH2D (FH2D-). Anthropometric measurements, including height, weight, waist circumference (WC), and blood pressure, were obtained. Blood samples were collected, fasting plasma glucose (FPG), serum lipids, Retinol Binding Protein 4 (RBP4), C reactive protein (CRP), adiponectin and visfatin were examined. Brachial-ankle pulse wave velocity (baPWV) was used to evaluate arterial stiffness. Visceral fat area (VFA) was measured by computerized tomography. Compared with FH2D- group, FH2D+ group had a significantly higher oral glucose tolerance test (OGTT) 2-hour insulin, RBP4 and baPWV levels, a lower adiponectin and glucose infusing rate (GIR) (P<0.05). BaPWV was positively correlated with age, systolic blood pressure (SBP), diastolic blood pressure (DBP), 2-hour (OGTT) insulin, RBP4, and VFA, and negatively correlated with GIR in FH2D+ group. After multivariate analysis, age, SBP, RBP4 and VFA maintained an independent association with baPWV in FH2D+ group (P<0.05), while only age, SBP, and VFA were independent predictors of baPWV in FH2D- group (P<0.05). These findings led to the conclusion that RBP4 level was associated with increased arterial stiffness in young subjects with family history of type 2 diabetes.
26868132	15	19	RBP4	T116,T123	C1438309
26868132	42	60	arterial stiffness	T039	C0599949
26868132	64	75	adolescents	T100	C0205653
26868132	81	114	family history of type 2 diabetes	T033	C2316287
26868132	131	136	study	T062	C2603343
26868132	166	199	family history of type 2 diabetes	T033	C2316287
26868132	201	205	FH2D	T033	C2316287
26868132	210	228	arterial stiffness	T039	C0599949
26868132	232	237	young	T079	C0332239
26868132	238	244	people	T098	C0027361
26868132	269	283	adipocytokines	T116,T123	C1955907
26868132	290	308	case-control study	T062	C0007328
26868132	321	332	adolescents	T100	C0205653
26868132	334	338	male	T032	C0086582
26868132	341	347	female	T032	C0086287
26868132	360	364	FH2D	T033	C2316287
26868132	366	371	FH2D+	T033	C2316287
26868132	380	391	adolescents	T100	C0205653
26868132	393	397	male	T032	C0086582
26868132	400	406	female	T032	C0086287
26868132	422	426	FH2D	T033	C2316287
26868132	428	433	FH2D-	T033	C1513916
26868132	436	463	Anthropometric measurements	T081	C0815129
26868132	475	481	height	T032	C0005890
26868132	483	489	weight	T032	C0005910
26868132	491	510	waist circumference	T201	C0455829
26868132	512	514	WC	T201	C0455829
26868132	521	535	blood pressure	T040	C0005823
26868132	552	565	Blood samples	T031	C0178913
26868132	582	604	fasting plasma glucose	T059	C0583513
26868132	606	609	FPG	T059	C0583513
26868132	612	624	serum lipids	T059	C0428462
26868132	626	651	Retinol Binding Protein 4	T116,T123	C1438309
26868132	653	657	RBP4	T116,T123	C1438309
26868132	660	678	C reactive protein	T059	C0201657
26868132	680	683	CRP	T059	C0201657
26868132	686	697	adiponectin	T059	C2700366
26868132	702	710	visfatin	T116,T126	C0068707
26868132	726	760	Brachial-ankle pulse wave velocity	T081	C3494431
26868132	762	767	baPWV	T081	C3494431
26868132	790	808	arterial stiffness	T039	C0599949
26868132	810	827	Visceral fat area	T201	C3654464
26868132	829	832	VFA	T201	C3654464
26868132	850	873	computerized tomography	T060	C0040405
26868132	889	894	FH2D-	T033	C1513916
26868132	895	900	group	T098	C1257890
26868132	902	907	FH2D+	T033	C2316287
26868132	908	913	group	T098	C1257890
26868132	941	990	oral glucose tolerance test (OGTT) 2-hour insulin	T059	C2041409
26868132	992	996	RBP4	T116,T123	C1438309
26868132	1001	1006	baPWV	T081	C3494431
26868132	1023	1034	adiponectin	T059	C2700366
26868132	1039	1060	glucose infusing rate	T079	C2964135
26868132	1062	1065	GIR	T079	C2964135
26868132	1077	1082	BaPWV	T081	C3494431
26868132	1114	1117	age	T032	C0001779
26868132	1119	1142	systolic blood pressure	T201	C0871470
26868132	1144	1147	SBP	T201	C0871470
26868132	1150	1174	diastolic blood pressure	T201	C0428883
26868132	1176	1179	DBP	T201	C0428883
26868132	1182	1203	2-hour (OGTT) insulin	T059	C2041409
26868132	1205	1209	RBP4	T116,T123	C1438309
26868132	1215	1218	VFA	T201	C3654464
26868132	1258	1263	FH2D+	T033	C2316287
26868132	1264	1269	group	T098	C1257890
26868132	1277	1298	multivariate analysis	T081	C0026777
26868132	1300	1303	age	T032	C0001779
26868132	1305	1308	SBP	T201	C0871470
26868132	1310	1314	RBP4	T116,T123	C1438309
26868132	1319	1322	VFA	T201	C3654464
26868132	1366	1371	baPWV	T081	C3494431
26868132	1375	1380	FH2D+	T033	C2316287
26868132	1381	1386	group	T098	C1257890
26868132	1408	1411	age	T032	C0001779
26868132	1413	1416	SBP	T201	C0871470
26868132	1422	1425	VFA	T201	C3654464
26868132	1443	1453	predictors	T078	C2698872
26868132	1457	1462	baPWV	T081	C3494431
26868132	1466	1471	FH2D-	T033	C1513916
26868132	1472	1477	group	T098	C1257890
26868132	1494	1502	findings	T033	C0243095
26868132	1530	1534	RBP4	T116,T123	C1438309
26868132	1571	1589	arterial stiffness	T039	C0599949
26868132	1593	1598	young	T079	C0332239
26868132	1599	1607	subjects	T098	C0080105
26868132	1613	1646	family history of type 2 diabetes	T033	C2316287